Merrimack Pharmaceuticals
MACK
#8022
Rank
C$0.31 B
Marketcap
$21.51
Share price
0.00%
Change (1 day)
7.64%
Change (1 year)

EPS for Merrimack Pharmaceuticals (MACK)

EPS in 2023 (TTM): -$0.15

According to Merrimack Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.16. In 2022 the company made an earnings per share (EPS) of -$0.16 an increase over its 2021 EPS that were of -$0.26.

EPS history for Merrimack Pharmaceuticals from 2010 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.15-5.01%
2022-$0.16-38.89%
2021-$0.26-25%
2020-$0.34-81.54%
2019-$1.85-56.95%
2018-$4.29-108.5%
2017$50.48-390.35%
2016-$17.38-7.35%
2015-$18.7665%
2014-$11.37-39.39%
2013-$18.76-54.01%
2012-$40.80-53.71%
2011-$88.1440.37%
2010-$62.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$4.52-2,991.14%๐Ÿ‡ซ๐Ÿ‡ท France
-$1.19 663.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.48 209.09%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.69 1,618.18%๐Ÿ‡บ๐Ÿ‡ธ USA
-$8.02 5,027.27%๐Ÿ‡บ๐Ÿ‡ธ USA